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Manipulating the Enone Moiety of Levoglucosenone:  
1,3-Transposition Reactions Including Ones Leading to Isolevoglucosenone† 
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a
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b
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––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
The manipulation of the enone moiety associated with the biomass-derived, 
homochiral and now abundant compound levoglucosenone (1) is described. While the 
trichloroacetimidates derived from the allylic alcohols 3 and 4 failed to engage in 
Overman-type rearrangements, certain ester derivatives reacted in the presence of 
Pd[0]-catalysts to give regio-isomeric mixtures of β,γ-unsaturated malonates or 
ketones, the structures of which were confirmed by single-crystal X-ray analyses. In 
other sequences involving 1,3-transposition reactions, an operationally simple means 
for converting compound 1 into isolevoglucosenone (2) is described. 
 
 
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
 
† Dedicated to the memory of Professor Sir Derek Barton and in recognition of his 
seminal contributions to so many aspects of organic chemistry. 
  
O
O
O
1
O
O
2
O
O
O
OH O
O
OH
3 4
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 2
INTRODUCTION 
Levoglucosenone (1) can be generated through the acid-catalysed depolymerisation of 
cellulose and recent refinements of this process have allowed for the production of 
this homochiral material on the tonne scale from various forms of biomass including 
waste paper and sawdust.1 As testimony to the scale and utility of this process, the 
ketone, Cyrene™, arising from the hydrogenation of the carbon-carbon double bond 
within compound 1, is now being employed in a number of countries as a replacement 
for the soon-to-be banned polar aprotic solvent N-methylpyrrolidinone (NMP).2 
Given both the sustainable nature and the scale of its production, levoglucosenone is 
likely to become an increasingly important starting material in chemical synthesis, 
and all the more so if new means for manipulating it in useful ways can be 
developed.3 The most obvious site for manipulation is the enone moiety and a range 
of methods for doing so has been reported in the literature,1,4 including by us.5 In 
particular, and like others,3 we have sought to convert compound 1 into its quasi-
enantiomer isolevoglucosenone (2). In our work5 this was achieved using Wharton 
rearrangement chemistry and these studies prompted us to consider other means by 
which the required and related 1,3-transposition processes could be implemented 
within the 6,8-dioxabicyclo[3.2.1]octane framework associated with levoglucosenone. 
The work detailed in the following sections reveals new means for doing so.        
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RESULTS AND DISCUSSION 
The [3,3]-sigmatropic rearrangement of derivatives of the epimeric allylic alcohols 
arising from the 1,2-reduction of levoglucosenone became the focal point of our 
initial studies and efficient means for obtaining the first of these substrates are shown 
in Scheme 1. Specifically, then, enone 1 was subjected to 1,2-reduction in methanol at 
0 °C using sodium borohydride in the presence of cerium trichloride and in this way a 
ca. 11:1 mixture of the anticipated and epimeric allylic alcohols 3 and 4 was obtained 
in 91% combined yield.6 These could not be separated by conventional means and so 
the mixture was acetylated under standard conditions and the product esters 56 (92%) 
and 66 (8%) were each isolated in pure form using flash chromatographic techniques 
and then fully characterized. Each was treated with potassium carbonate in methanol 
and thus regenerating the corresponding and now epimerically pure allylic alcohols 3 
(97%) and 4 (92%), respectively. The spectral data acquired on these were in 
agreement with those reported in the literature.6 The preferential formation of epimer 
3 in the initial reduction step is entirely consistent with previous observations and 
necessarily arises through selective delivery of hydride from the sterically less 
congested α-face of the enone moiety in substrate 1 (the corresponding β-face being 
shielded by the presence of the sterically demanding 1,6-anhydro-bridge).      
     
 
Scheme 1 
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In order to secure workable quantities of the minor epimeric alcohol 4 for further 
study, the straightforward reaction sequence shown in Scheme 2 was developed. 
Specifically, then, the more abundant allylic alcohol 3 was subjected to a Mitsunobu 
reaction using triphenylphosphine/diethyl azodicarboxylate (DEAD) for activation 
and α-chloroacetic acid as the nucleophile.6,7 By such means the inverted allylic α-
chloroacetate 7 was obtained in 86% yield and when this was saponified using 
potassium carbonate in methanol then the target alcohol 4 was obtained in 85% yield.     
 
 
Scheme 2 
 
The structures of all of the products of the reactions shown in Schemes 1 and 2 were 
confirmed by single-crystal X-ray analyses of derivatives of compounds 3 and 4. 
Details of these analyses are presented below, including in the Experimental Section 
as well as in the Supplementary Information.  
 
With allylic alcohols 3 and 4 now each available in useful quantities, an investigation 
into the participation of certain derivatives in [3,3]-sigmatropic rearrangement 
reactions began. Given our successes8 in applying the Eschenmoser-Claisen 
rearrangement to various 2-cyclohexen-1-ols, each of compounds 3 and 4 was treated 
with N,N-dimethylacetamide dimethyl acetal in refluxing toluene but to no avail. 
Similarly, all attempts to effect Ireland-Claisen-type rearrangements9 of acetates 5 and 
6 under standard conditions also failed. In each instance either the relevant starting 
material (viz. 3-6) was returned or, under more forcing conditions (involving higher 
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reaction temperatures), decomposition was observed. In an effort to engage allylic 
alcohols 3 and 4 in Overman rearrangement reactions,10 an o-xylene/THF or 
dichloromethane/THF solution of each was treated (Scheme 3) with 
trichloroacetonitrile in the presence of either sodium hexamethyldisilazide 
(NaHMDS) or 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) and thereby affording the 
anticipated and crystalline trichloroacetimidates 8 (87%) and 9 (78%), respectively. 
The structure of each of products 8 and 9 was confirmed by single-crystal X-ray 
analysis, details of which are reported in the Experimental Section. Of course, these 
analyses also serve to confirm the structures of precursors 3 and 4 as well as the 
corresponding acetates.  
 
 
Scheme 3 
 
Unfortunately, all attempts thus far to induce the Overman rearrangement of 
compounds 8 and 9 under a variety of conventional conditions failed. Once again, 
either the starting material was returned or, under more forcing conditions, 
decomposition was observed. 
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as the catalyst, the sodium salt of dimethyl malonate as the nucleophile and 1,2-
bis(diphenylphosphino)ethane (dppe) as an added ligand (Scheme 4)11,12 – in the 
absence of dppe the illustrated transformations did not proceed very effectively at all. 
Under such conditions compound 5 reacted to give a chromatographically separable 
mixture of the regio-isomeric diesters 10 (44%) and 11 (32%), each of which was 
crystalline and the structures of which could, therefore, be confirmed by single-crystal 
X-ray analysis (see Experimental Section for details). Similar treatment of the 
epimeric allylic acetate 6 also gave a mixture of compounds 10 (31%) and 11 (49%). 
When reacted with LiCl in DMSO at 140 °C each of the product malonates was 
converted, via a demethylation/decarboxylation process (Krapcho decarboxylation),13 
into the corresponding methyl acetate derivatives, namely compounds 12 (79%) and 
13 (82%).  
 
 
Scheme 4 
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The origins of the selectivities observed in the processes leading to malonates 10 and 
11 remain to be established but the similarities of the outcomes are suggestive of the 
involvement of a common intermediate. This is most likely to be the pi-allyl palladium 
complex in which the transition metal is co-ordinated to that face of the pi-system 
opposite the 1,6-anhydro-bridge. The formation of this intermediate from precursor 5 
would presumably follow a conventional (inversion) pathway but precisely how this 
same species is formed from epimer 6 is less obvious. It could be that interconversion 
of the two possible (pi-allyl)palladium complexes is taking place or that syn-
displacement of the acetate leaving group by Pd[0] is occurring.14 Regardless, of the 
precise pathway involved, these results seem at odds with those of Matsumoto et al 
who reported12 that the allylic and α-configured chloride corresponding to compound 
6 reacts under essentially the same conditions to give a mixture of the epimeric forms 
of compounds 10 and 11. Unfortunately, no spectral data were reported for 
Matsumoto’s products and so relevant comparisons with our own (which are 
presented in the Experimental Section) cannot be made.  
A stereo-complementary outcome to the one just described was observed when the 
palladium-catalysed Carroll-type rearrangement15 was applied to the β-keto-esters 
derived from the epimeric alcohols 3 and 4 (Scheme 5). So, for example, treatment of 
the anion derived from alcohol 3 with readily available 2,2,6-trimethyl-4H-1,3-
dioxin-4-one (14)16 afforded the β-keto-ester 15 (94%) that upon treatment with 
(Ph3P)4Pd in refluxing toluene afforded a ca. 2:1 and chromatographically separable 
mixture of the regio-isomeric γ,δ-unsaturated methyl ketones 16 and 17 (55% 
combined yield). When the epimeric β-keto-ester 18, readily obtained in 90% by 
treating the oxyanion derived from alcohol 4 with electrophile 14, was exposed to 
(Ph3P)4Pd in refluxing toluene then a ca. 3:1 mixture of compounds 16 and 17 was 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 8
obtained in 56% combined yield. Once again, the outcomes of this pair of reactions 
suggest the involvement of a common intermediate, probably the pi-allyl palladium 
complex in which the metal is co-ordinated to that face of the pi-system opposite the 
1,6-anhydro-bridge and carrying, at the metal center, a carboxylate- or enolate-based 
ligand. This intermediate is presumably generated from substrate 15 in a conventional 
manner while its production from precursor 18 could involve pre-complexation of the 
palladium by the α-oriented and bidentate β-keto-ester residue. Regardless of the 
precise details of the Tsuji-Trost-type chemistries shown in Schemes 4 and 5, it seems 
that the intermediate pi-allyl complexes invariably involve α-face selective co-
ordination of the palladium.       
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Scheme 5 
 
Given the pivotal nature of these conclusions, it was crucial to unambiguously 
establish the structure of each of products 16 and 17. In the case of the former 
compound, this was done by the means outlined in Scheme 6. Specifically, compound 
16 was treated with methylmagnesium bromide and the ensuing 3°-alcohol 19 (93%) 
then converted, under standard conditions, into the corresponding 3,5-dinitrobenzoate 
20 (89%). This proved to be a crystalline compound and its structure could thus be 
determined by single-crystal X-ray analysis, details of which are provided in the 
Experimental Section.  
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Scheme 6 
 
In an analogous manner, ketone 17 was converted into the 3°-alcohol 21 (85%) 
(Scheme 7) on treatment with methylmagnesium bromide and this was, in turn, 
transformed into the corresponding 3,5-dinitrobenzoate 22 (90%) on exposure to 3,5-
dinitrobenzoyl chloride in the presence of pyridine and DMAP. Compound 22 also 
proved to be a crystalline material and so its structure, too, was confirmed by single-
crystal X-ray analysis.  
 
 
Scheme 7 
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sodium borohydride in methanol then gave a ca. 4:3 mixture of the epimeric forms of 
alcohol 24 (62% combined yield), the structure of the α-configured one being 
confirmed by single crystal X-ray analysis. Acetylation of each of these alcohols 
using acetic anhydride in the presence of DMAP gave the corresponding and epimeric 
acetates 25 (99%). On exposure of these to tetra-n-butylammonium fluoride (TBAF) 
the anticipated epimeric forms of alcohol 2618 (90%) were obtained and when these 
were subjected to sequential treatment with pyridinium chlorochromate (PCC) and 
sodium acetate then isolevoglucosenone (2) was obtained in 53% yield. This material 
was identical, in all respects, to an authentic sample prepared by our earlier route.5  
 
 
Scheme 8 
 
Since the reaction sequence shown in Scheme 8 represents a rather minor variation on 
the route (from 1 → 2) developed sometime ago by Furneaux and co-workers,17 
attempts were made to establish a more concise pathway to target 2. To such ends, 
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chromatographically separable mixture of the mono-oxidation products 23 (10%) and 
2819 (39%) was obtained. Treatment of the latter compound with p-toluenesulfonyl 
chloride (p-TsCl) and triethylamine in acetonitrile then gave, presumably via an E1cb 
elimination reaction involving the intermediate tosylate, isolevoglucosenone (2) in 
65% yield.  
 
 
Scheme 9 
 
In an effort to improve the efficiency of this three-step reaction sequence, various 
attempts were made to increase the selectivity and yield of the oxidation process 
leading to compound 28 but, thus far, to no avail. As such, the longer route (Scheme 
8) remains the slightly higher yielding one (21% vs 18%) despite the additional steps 
involved. That said, further refinements of the shorter pathway seem warranted and 
are now being investigated. The outcomes of our efforts in this area will be reported 
in due course. 
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particular, and as shown in Scheme 10, compound 2 could be reduced in a completely 
stereoselective manner under Luche-type conditions to give the known allylic alcohol 
29. The illustrated β-configuration at the newly established stereogenic center is 
assigned on the basis that the steric demands of the 1,6-anhydrobridge in substrate 2 
should direct hydride deliver to the α-face of the enone moiety. Acetylation of 
compound 29 was effected under standard conditions and the resulting and previously 
reported ester 30 (88% over two steps) was then subjected to reaction with the sodium 
salt of dimethyl malonate in the presence of (Ph3P)4Pd and dppe to afford a mixture of 
the regio-isomeric di-esters 10 (42%) and 11 (53%). Thus, a similar product 
distribution is seen here as was observed when the regio-isomeric allylic acetate 5 
(Scheme 4) was subjected to these same Tsuji-Trost reaction conditions. Of course, 
such outcomes suggest that both reactions are proceeding, as would be expected, 
through a common pi-allyl palladium complex.  
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CONCLUSIONS 
We have described a series of palladium-catalysed and stereocontrolled (but non-
regio-selective) 1,3-transpostion reactions of various esters of the alcohols 3 and 4 
derived from levoglucosenone (1). In each case a pi-allyl palladium complex wherein 
the transition metal is co-ordinated to the less hindered α-face of the bicyclic 
framework is likely to be involved. While the [3,3]-sigmatropic rearrangement of 
various derivatives of compounds 3 and 4 could not be implemented, the facile 
conjugate addition of water to enone 1 allowed for the development of simple 
synthetic routes to its quasi-enantiomer isolevoglucosenone (2) and a capacity, 
therefore, to study the chemistry of this less-explored isomer. 
 
Taken together, the processes described above add to the repertoire of chemical 
transformations that can be applied to levoglucosenone (1), a homochiral and 
increasingly readily available building block that can be produced in a sustainable 
fashion and that is, therefore, likely to continue to assume increasing importance as a 
starting material in chemical synthesis.  
 
EXPERIMENTAL SECTION 
General Experimental Procedures 
Unless otherwise specified, proton (1H) and carbon (13C) NMR spectra were recorded 
at 18 °C in base-filtered CDCl3 on a spectrometer operating at 400 MHz for proton 
and 100 MHz for carbon nuclei. 1H NMR data are recorded as follows: chemical shift 
(δ) [multiplicity, coupling constant(s) J (Hz), relative integral] where multiplicity is 
defined as s = singlet; d = doublet; t = triplet; q = quartet; m = multiplet or 
combinations of the above. In relevant cases, the signal due to residual CHCl3 
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appearing at δH 7.26 and the central resonance of the CDCl3 “triplet” appearing at δC 
77.0 were used to reference 1H and 13C NMR spectra, respectively. Samples were 
analyzed by infrared spectroscopy (νmax) as thin films on KBr plates. Optical rotations 
were recorded using the sodium D-line (589 nm) in a cell with a path length of 1 dm, 
at the concentrations indicated and in the specified solvent at 22 °C. Specific rotations 
were then calculated in the usual manner. Low- and high-resolution electron impact 
(EI) mass spectra were recorded on a double focusing, triple sector machine. Low- 
and high-resolution ESI mass spectra were recorded on a triple-quadrupole mass 
spectrometer operating in positive ion mode. Melting points are uncorrected. 
Analytical thin layer chromatography (TLC) was performed on aluminum-backed 0.2 
mm thick silica gel 60 F254 plates. Eluted plates were visualized using a 254 nm UV 
lamp and/or by treatment with a suitable dip followed by heating. These dips included 
phosphomolybdic acid/ceric sulfate/sulfuric acid (conc.)/water (37.5 g : 7.5 g : 37.5 g 
: 720 mL), potassium permanganate/potassium carbonate/5% sodium hydroxide 
aqueous solution/water (3 g : 20 g : 5 mL : 300 mL), and p-anisaldehyde or 
vanillin/sulfuric acid (conc.)/ethanol (15 g : 2.5 mL : 250 mL). Flash chromatographic 
separations were carried out following protocols defined by Still et al.20 with silica gel 
60 (40-63 µm) as the stationary phase and using the AR- or HPLC-grade solvents 
indicated. The melting points of solids purified by such means were recorded directly 
(ie after they had crystallized from the concentrated chromatographic fractions). 
Starting materials, reagents, drying agents, and other inorganic salts were generally 
commercially available and were used as supplied. Tetrahydrofuran (THF), methanol 
and dichloromethane were dried using a solvent purification system that is based upon 
a technology originally described by Grubbs et al.21 Where necessary, reactions were 
performed under a nitrogen atmosphere. 
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Specific Chemical Transformations 
Compounds 5 and 6. Step i: A magnetically stirred solution of compound 1 (1.00 g, 
7.93 mmol) in methanol (25 mL) maintained at 0 °C was treated with CeCl3•7H2O 
(3.00 g, 8.05 mmol) then, in portions, with NaBH4 (300 mg, 7.93 mmol). The ensuing 
mixture was stirred at 0 °C for 1 h before being concentrated under reduced pressure. 
The residue thus obtained was subjected to flash chromatography (silica, 2:1 v/v ethyl 
acetate/hexane elution) to give, after concentration of the appropriate fractions (Rf = 
0.5 in 5:4:1 v/v/v ethyl acetate/hexane/methanol), an inseparable mixture of 
compounds 3 and 4 (922 mg, 91%) as a white, crystalline solid.  
Step ii: A magnetically stirred solution of compounds 3 and 4 (658 mg, 5.14 mmol) in 
pyridine (10 mL) was treated with acetic anhydride (2.00 mL, 21.16 mmol) then 
DMAP (14 mg, 0.11 mmol). After stirring the ensuing mixture at 22 °C for 2 h, the 
reaction mixture was concentrated under reduced pressure and the residue thus 
obtained subjected to flash chromatography (silica, gradient elution from 1:25 → 1:4 
v/v ethyl acetate/petroleum benzene elution) to deliver two fractions, A and B. 
Concentration of fraction A (Rf = 0.3 in 2:2.5:5.5 v/v/v ethyl acetate/dichloromethane 
/hexane) gave compound 5 (802 mg, 92%) as a clear, colorless oil, [α]D = −38 (c = 
0.1, CHCl3): 1H NMR (400 MHz, CDCl3) δ 6.20 (m, 1H), 5.58 (m, 2H), 5.51 (m, 1H), 
4.69 (t, J = 4.2 Hz, 1H), 3.98 (d, J = 6.6 Hz, 1H), 3.80 (m, 1H), 2.13 (s, 3H); 13C 
NMR (100 MHz, CDCl3) δ 170.8 (C), 132.6 (CH), 124.9 (CH), 99.3 (CH), 71.8 (CH), 
71.6 (CH2), 71.5 (CH), 21.2 (CH3); IR νmax 2963, 2891, 1729, 1371, 1230, 1124, 
1038, 981, 883, 802 cm–1; MS (ESI, +ve) m/z 193 [(M+Na)+, 100%]; HRMS (M+H)+ 
calcd for C8H11O4 171.0652, found 171.0649.  
Concentration of fraction B (Rf = 0.4 in 2:2.5:5.5 v/v/v ethyl acetate/dichloromethane 
/hexane) gave compound 6 (70 mg, 8%) as a clear, colorless oil, [α]D = −265 (c = 0.1, 
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CHCl3): 1H NMR (400 MHz, CDCl3) δ 6.31 (ddd, J = 9.8, 4.7 and 1.5 Hz, 1H), 5.74 
(m, 1H), 5.53 (t, J = 1.5 Hz, 1H), 4.76 (m, 2H), 3.71 (m, 2H), 2.10 (s, 3H); 13C NMR 
(100 MHz, CDCl3) δ 170.2 (C), 132.7 (CH), 122.9 (CH), 100.4 (CH), 70.5 (CH), 69.3 
(CH2), 66.5 (CH), 21.1 (CH3); IR νmax 3051, 2965, 2894, 1735, 1475, 1372, 1235, 
1126, 1023, 885, 867, 800, 712 cm–1; MS (ESI, +ve) m/z 193 [(M+Na)+, 100%]; 
HRMS (M+Na)+ calcd for C8H10O4Na 193.0477, found 193.0476. 
Compound 3. A magnetically stirred solution of compound 5 (343 mg, 2.016 mmol) 
in methanol (5 mL) maintained at 22 °C was treated with K2CO3 (557 mg, 4.03 
mmol). The resulting mixture was stirred for 2 h then concentrated under reduced 
pressure and the residue thus obtained subjected to flash chromatography (silica, 1.5:1 
v/v ethyl acetate/petroleum spirit elution) to afford, after concentration of the 
appropriate fractions (Rf = 0.5 in 5:4:1 v/v/v ethyl acetate/hexane/methanol), 
compound 3 (249 mg, 97%) as a white, crystalline solid, m.p. = 58-60 °C, [α]D = 
+190 (c = 0.2, CHCl3): 1H NMR (400 MHz, CDCl3) δ 6.03 (m, 1H), 5.85 (m, 1H), 
5.52 (m, 1H), 4.67 (m, 1H), 3.95 (m, 1H), 3.65 (m, 1H), 3.47 (m, 1H), 2.32 (broad s, 
1H); 13C NMR (100 MHz, CDCl3) δ 130.3 (CH), 126.4 (CH), 95.7 (CH), 77.0 (CH), 
67.3 (CH), 62.7 (CH2); IR νmax 3401, 2976, 2891, 1385, 1170, 1096, 1053, 1010, 897, 
709 cm–1; MS (ESI, +ve) m/z 151 [(M+Na)+, 100%], 129 [(M+H)+, <1]; HRMS 
(M+H)+ calcd for C6H9O3 129.0546, found 129.0544. 
Compound 7. A magnetically stirred a solution of compound 3 (180 mg, 1.41 mmol) 
in THF (20 mL) maintained at 22 °C was treated with α-chloroacetic acid (266 mg, 
2.82 mmol), triphenylphosphine (737 mg, 2.81 mmol) then diethyl azodicarboxylate 
(440 µL, 2.79 mmol). The ensuing mixture was stirred at 22 °C for 18 h then 
concentrated under reduced pressure. Subjection of the residue thus obtained to flash 
chromatography (silica, 2:25 v/v ethyl acetate/petroleum ether elution) afforded, after 
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concentration of the appropriate fractions (Rf = 0.4 in 2:2.5:5.5 v/v/v ethyl 
acetate/dichloromethane/hexane), compound 7 (246 mg, 86%) as a white, crystalline 
solid, m.p. = 61-63 °C, [α]D = −214 (c = 0.2, CHCl3): 1H NMR (400 MHz, CDCl3) δ 
6.35 (ddd, J = 9.9, 4.7 and 1.1 Hz, 1H), 5.79 (ddd, J = 9.9, 3.9 and 2.0 Hz, 1H), 5.55 
(m, 1H), 4.81 (m, 1H), 4.77 (m, 1H), 4.10 (d, J = 0.9 Hz, 2H), 3.71 (m, 2H); 13C 
NMR (100 MHz, CDCl3) δ 166.6 (C), 133.4 (CH), 122.0 (CH), 100.0 (CH), 70.5 
(CH), 69.2 (CH2), 67.9 (CH), 40.9 (CH2); IR νmax 2961, 2895, 1758, 1326, 1295, 
1260, 1169, 1126, 1020, 1000, 969, 911, 892, 804 cm–1; MS (ESI, +ve) m/z 229 and 
227 [(M+Na)+, 30 and 100%]; HRMS (M+Na)+ calcd for C8H935ClO4Na 227.0087, 
found 227.0086. 
Compound 4 (from compound 6). A magnetically stirred solution of compound 6 (70 
mg, 0.41 mmol) in methanol (2.0 mL) maintained at 22 °C was treated with K2CO3 
(170 mg, 1.22 mmol). The resulting mixture was stirred for 2 h then concentrated 
under reduced pressure. Subjection of the residue thus obtained to flash 
chromatography (silica, 1.5:1 v/v ethyl acetate/petroleum ether elution) afforded, after 
concentration of the appropriate fractions (Rf = 0.5 in 5:4:1 v/v/v ethyl 
acetate/hexane/methanol), compound 4 (49 mg, 92%) as a white, crystalline solid, 
m.p. = 57-59 °C, [α]D = −242 (c = 0.2, CHCl3): 1H NMR (400 MHz, CDCl3) δ 6.18 
(ddd, J = 9.8, 4.7 and 1.0 Hz, 1H), 5.81 (ddd, J = 9.8, 4.0 and 2.0 Hz, 1H), 5.52 (m, 
1H), 4.68 (m, 1H), 3.68 (m, 2H), 3.63 (d, J = 3.9 Hz, 1H), 1.92 (s, 1H); 13C NMR 
(100 MHz, CDCl3) δ 131.0 (CH), 126.6 (CH), 102.8 (CH), 70.8 (CH), 69.1 (CH2), 
66.0 (CH); IR νmax 3400, 2959, 2892, 1403, 1123, 1052, 1029, 921, 892, 862, 851, 
796, 727 cm–1; MS (ESI, +ve) m/z 151 [(M+Na)+, 100%], 129 [(M+H)+, <1]; HRMS 
(M+H)+ calcd for C6H9O3 129.0546, found 129.0544. 
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Compound 4 (from compound 7). Following a procedure similar to that described 
immediately above, ester 7 (355 mg, 1.74 mmol) was converted into alcohol 4 (189 
mg, 85%). This product was identical, in all respects, with an authentic sample. 
Compound 8. A magnetically stirred solution of compound 3 (500 mg, 3.90 mmol) 
and trichloroacetontrile (470 µL, 4.69 mmol) in o-xylene (30 mL) maintained under a 
nitrogen atmosphere at 0 °C was treated with NaHMDS (780 µL of a 1.0 M solution 
in THF, 0.78 mmol). The ensuing mixture was stirred at 0 °C for 1 h then warmed to 
22 °C before being concentrated under reduced pressure. The residue thus obtained 
was subjected to flash chromatography (silica, 1:1 v/v diethyl ether/hexane elution) to 
afford, after concentration of the appropriate fractions (Rf = 0.4 in 1:2.5:5.5 v/v/v 
ethyl acetate/dichloromethane/hexane), compound 8 (929 mg, 87%) as a white, 
crystalline solid, m.p. = 88-90 °C, [α]D = −29 (c = 0.1, CHCl3): 1H NMR (400 MHz, 
CDCl3) δ 8.41 (s, 1H), 6.26 (m, 1H), 5.86 (m, 1H), 5.77 (dt, J = 9.9 and 2.2 Hz, 1H), 
5.65 (m, 1H), 4.71 (t, J = 4.2 Hz, 1H), 4.02 (d, J = 6.6 Hz, 1H), 3.82 (m, 1H); 13C 
NMR (100 MHz, CDCl3) δ 162.4 (C), 133.1 (CH), 124.3 (CH), 98.6 (CH), 76.1 (CH), 
71.6 (CH2), 71.5 (CH) (signal due to one carbon obscured/overlapping); IR νmax 3341, 
2981, 2891, 1664, 1358, 1334, 1275, 1124, 1077, 1032, 796 cm–1; MS (EI, 70 eV) m/z 
275, 273 and 271 (M+•, 1, 3 and 3%), 240, 238  and 236 (12, 48 and 75), 208 (59), 
206 (45), 119 (95), 117 (100), 97 (37); HRMS M+• calcd for C8H835Cl3NO3 270.9570, 
found 270.9562. 
Compound 9. DBU (82 µL, 0.55 mmol) was added to a magnetically stirred solution 
of compound 4 (351 mg, 2.74 mmol) and trichloroacetontrile (330 µL, 3.29 mmol) in 
dichloromethane (25 mL) maintained under a nitrogen atmosphere at 0 °C. The 
ensuing solution was stirred at 0 °C for 0.5 h then warmed to 22 °C before being 
concentrated under reduced pressure. The residue thus obtained was subjected to flash 
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chromatography (silica, 1:1 v/v diethyl ether/hexane elution) to afford, after 
concentration of the appropriate fractions (Rf = 0.4 in 1:2.5:5.5 v/v/v ethyl 
acetate/dichloromethane/hexane), compound 9 (557 mg, 78%) as a white, crystalline 
solid, m.p. = 89-91 °C, [α]D = −146 (c = 0.1, CHCl3): 1H NMR (400 MHz, CDCl3) δ 
8.45 (broad s, 1H), 6.39 (m, 1H), 5.93 (ddd, J = 9.8, 3.8 and 1.9 Hz, 1H), 5.70 (m, 
1H), 4.90 (m, 1H), 4.80 (m, 1H), 3.73 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 161.9 
(C), 133.3 (CH), 122.1 (CH), 99.7 (CH), 70.6 (CH), 70.4 (CH), 69.1 (CH2) (signal 
due to one carbon obscured/overlapping); IR νmax 3339, 2964, 2894, 1662, 1352, 
1329, 1272, 1126, 1060, 1020, 997, 871, 831, 792, 645 cm–1; MS (EI, 70 eV) m/z 275, 
273 and 271 (M+•, 0.5, 1 and 1%), 240, 238 and 236 (9, 29 and 45), 208 (60), 206 
(65), 119 (95), 117 (100), 97 (34); HRMS M+• calcd for C8H835Cl3NO3 270.9570, 
found 270.9567. 
Compounds 10 and 11 (from compound 5). Sodium hydride (76 mg of a 60% 
dispersion in mineral oil, 1.90 mmol) was added, in portions, to a magnetically stirred 
solution of dimethyl malonate (225 µL, 1.97 mmol) in THF (18 mL) maintained 
under a nitrogen atmosphere at 0 °C. The ensuing mixture was stirred for 1 h at 0 °C 
then added to a magnetically stirred solution of compound 5 (104 mg, 0.61 mmol), 
Pd(Ph3P)4 (35 mg, 0.03 mmol) and ethylenebis(diphenylphosphine) (24 mg, 0.06 
mmol) in THF (7 mL) maintained under a nitrogen atmosphere at 22 °C. The ensuing 
mixture was heated under reflux for 18 h then cooled and concentrated under reduced 
pressure. The residue thus obtained was subjected to flash chromatography (silica, 
1:20 → 1:10 v/v ethyl acetate/hexane gradient elution) and so affording two fractions, 
A and B.  
Concentration of fraction A (Rf = 0.4 in 2:2.5:5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) gave compound 10 (66 mg, 44%) as a white, 
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crystalline solid, m.p. = 84-86 °C, [α]D = +18 (c = 0.5, CHCl3): 1H NMR (400 MHz, 
CDCl3) δ 5.90 (m, 1H), 5.55 (d, J = 9.8 Hz, 1H), 5.50 (m, 1H), 4.56 (broad s, 1H), 
3.88 (m, 2H), 3.79 (s, 3H), 3.77 (s, 3H), 3.65 (m, 1H), 3.30 (d, J = 12.0 Hz, 1H); 13C 
NMR (100 MHz, CDCl3) δ 167.9 (C), 167.8 (C), 128.5 (CH), 126.5 (CH), 96.0 (CH), 
73.9 (CH), 63.8 (CH2), 53.1 (CH3), 53.0 (CH3), 51.8 (CH), 40.7 (CH); IR νmax 2956, 
2898, 1752, 1735, 1436, 1256, 1152, 1126, 1072, 1036, 981, 906, 712 cm–1; MS (EI, 
70 eV) m/z 242 (M+•, 8%), 211 (30), 183 (30), 178 (31), 150 (27), 132 (50), 111 (57), 
81 (100), 59 (43); HRMS M+• calcd for C11H14O6 242.0790, found 242.0790.  
Concentration of fraction B (Rf = 0.4 in 2:2.5:5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) gave compound 11 (48 mg, 32%) as a white, 
crystalline solid, m.p. = 36-38 °C, [α]D = −7 (c = 0.5, CHCl3): 1H NMR (400 MHz, 
CDCl3) δ 6.11 (m, 1H), 5.69 (s, 1H), 5.50 (m, 1H), 4.63 (m, 1H), 3.89 (d, J = 6.5 Hz, 
1H), 3.77 (s, 3H), 3.75 (s, 3H), 3.71 (m, 1H), 3.53 (d, J = 10.5 Hz, 1H), 3.31 
(broadened d, J = 10.5 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 168.7 (C), 168.2 (C), 
130.6 (CH), 125.7 (CH), 101.4 (CH), 73.0 (CH2), 70.8 (CH), 52.9 (CH3), 52.8 (CH3), 
52.1 (CH), 43.0 (CH); IR νmax 2955, 2890, 1751, 1735, 1436, 1261, 1151, 1122, 1072, 
1053, 1019, 988, 885 cm–1; MS (EI, 70 eV) m/z 242 (M+•, 1%), 211 (56), 153 (47), 
137 (72), 132 (80), 81 (100), 79 (60), 59 (58); HRMS M+• calcd for C11H14O6 
242.0790, found 242.0786.  
Compounds 10 and 11 (from compound 6). Following the same procedure as 
described immediately above, compound 6 (104 mg, 0.61 mmol) was converted into a 
mixture of compounds 10 (46 mg, 31%) and 11 (73 mg, 49%). Each of these products 
was identical with an authentic sample. 
Compound 12. A magnetically stirred solution of compound 10 (62 mg, 0.26 mmol) 
in DMSO (7 mL) was treated with LiCl (54 mg, 1.27 mmol) and water (5 drops). The 
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resulting mixture was heated at 140 °C for 2 h then cooled to 22 °C and subjected to 
flash chromatography (silica, 2:5 v/v ethyl acetate/hexane elution). Concentration of 
the appropriate fractions (Rf = 0.3 in 2:2.5:5.5 v/v/v ethyl 
acetate/dichloromethane/hexane) afforded compound 12 (37 mg, 79%) as a clear, 
colorless oil, [α]D = −35 (c = 1.0, CHCl3): 1H NMR (400 MHz, CDCl3) δ 5.84 (m, 
1H), 5.58 (m, 1H), 5.49 (m, 1H), 4.58 (m, 1H), 3.85 (m, 2H), 3.70 (s, 3H), 3.37 (m, 
1H), 2.36 (m, 1H), 2.27 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 171.8 (C), 128.8 
(CH), 127.5 (CH), 96.0 (CH), 75.0 (CH), 63.3 (CH2), 52.0 (CH3), 37.6 (CH), 34.2 
(CH2); IR νmax 2956, 2899, 1735, 1436, 1262, 1198, 1168, 1121, 1071, 1035, 969, 903 
cm–1; MS (EI, 70 eV) m/z 184 (M+•, 4%), 153 (19), 124 (24), 95 (21), 81 (61), 32 
(100); HRMS M+• calcd for C9H12O4 184.0736, found 184.0741. 
Compound 13. A magnetically stirred solution of compound 11 (110 mg, 0.45 mmol) 
in DMSO (7 mL) was treated with LiCl (96 mg, 2.26 mmol) then water (6 drops). The 
resulting mixture was heated at 140 °C for 18 h then cooled to 22 °C and subjected to 
flash chromatography (silica, 2:5 v/v ethyl acetate/hexane elution). Concentration of 
the appropriate fractions (Rf = 0.3 in 2:2.5:5.5 v/v/v ethyl acetate/ 
dichloromethane/hexane) afforded compound 13 (69 mg, 82%) as a clear, colorless 
oil, [α]D = −46 (c = 1.0, CHCl3): 1H NMR (400 MHz, CDCl3) δ 6.03 (m, 1H), 5.59 
(m, 1H), 5.53 (m, 1H), 4.62 (t, J = 4.4 Hz, 1H), 3.88 (d, J = 6.3 Hz, 1H), 3.72 (m, 
1H), 3.70 (s, 3H), 3.02 (m, 1H), 2.53 (dd, J = 16.4 and 8.0 Hz, 1H), 2.34 (dd, J = 16.4 
and 7.3 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 172.6 (C), 129.2 (CH), 128.1 (CH), 
102.0 (CH), 73.0 (CH2), 70.8 (CH), 51.8 (CH3), 39.8 (CH), 34.3 (CH2); IR νmax 2953, 
2887, 1734, 1437, 1348, 1264, 1166, 1122, 1071, 1051, 1018, 985, 880, 802 cm–1; 
MS (EI, 70 eV) m/z 184 (M+•, 3%), 153 (65), 124 (73), 96 (87), 81 (100), 79 (95), 59 
(57); HRMS M+• calcd for C9H12O4 184.0736, found 184.0730. 
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Compound 15. Sodium hydride (200 mg, 60% dispersion in mineral oil, 5.0 mmol) 
was cautiously added to a magnetically stirred solution compound 3 (325 mg, 2.54 
mmol) and 2,2,6-trimethyl-1,3-dioxin-4-one (14)16 (0.5 mL, 3.80 mmol) in THF (15 
mL) maintained under a nitrogen atmosphere at 0 °C. After a further 1 h the reaction 
mixture was quenched with a small amount of ice then concentrated under reduced 
pressure. The residue thus formed was subjected to flash chromatography (silica, 1:2 
v/v ethyl acetate/petroleum ether elution) to afford, after concentration of the 
appropriate fractions (Rf = 0.4 in 4:2.5:5.5 v/v/v ethyl acetate/ 
dichloromethane/hexane), compound 15 and ca. 10% of a mono-enolic tautomer (506 
mg, 94%) as a clear, colorless oil, [α]D = −27 (c = 0.2, CHCl3): 1H NMR (400 MHz, 
CDCl3) δ (major tautomer) 6.21 (m, 1H), 5.69 (m, 2H), 5.64 (m, 1H), 4.69 (t, J = 4.2 
Hz, 1H), 3.95 (d, J = 6.6 Hz, 1H), 3.79 (m, 1H), 3.53 (s, 2H), 2.27 (s, 3H); 13C NMR 
(100 MHz, CDCl3) δ (major tautomer) 200.2 (C), 167.1 (C), 133.0 (CH), 124.4 (CH), 
99.0 (CH), 71.6 (CH), 71.5(2) (CH2), 71.4(6) (CH), 50.1 (CH2), 30.3 (CH3); IR νmax 
2965, 2894, 1742, 1715, 1647, 1411, 1359, 1261, 1149, 1124, 1038, 983, 884 cm–1; 
MS (ESI, +ve) m/z 235 [(M+Na)+, 100%]; HRMS [(M+Na)+ calcd for C10H12O5Na 
235.0582, found 235.0583. 
Compounds 16 and 17 (from compound 15). A magnetically stirred solution of 
compound 15 (177 mg, 0.83 mmol) in dry, degassed toluene (15 mL) maintained 
under nitrogen was treated with (Ph3P)4Pd (96 mg, 0.08 mmol). The ensuing mixture 
was heated under reflux for 18 h then cooled to 22 °C and concentrated under reduced 
pressure. The residue thus obtained was subjected to flash chromatography (silica, 
1:10 → 1:5 v/v ethyl acetate/hexane elution gradient elution) to deliver two fractions, 
A and B. 
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Concentration of fraction A (Rf = 0.4 in 4:2.5:5.5 v/v/v ethyl acetate/ 
dichloromethane/hexane) gave compound 16 (52 mg, 37%) as a clear, colorless oil, 
[α]D = +157 (c = 0.2, CHCl3): 1H NMR (400 MHz, CDCl3) δ 5.87 (m, 1H), 5.62 (m, 
1H), 5.44 (d, J = 3.3 Hz, 1H), 4.40 (m, 1H), 3.98 (m, 1H), 3.68 (m, 1H), 2.87 (dd, J = 
18.4 and 8.9 Hz, 1H), 2.59 (dd, J = 18.4 and 4.9 Hz, 1H), 2.43 (m, 1H), 2.17 (s, 3H); 
13C NMR (100 MHz, CDCl3) δ 207.1 (C), 128.5 (CH), 128.1 (CH), 96.1 (CH), 74.8 
(CH), 67.5 (CH2), 45.2 (CH2), 37.8 (CH), 30.5 (CH3); IR νmax 2971, 2894, 1713, 1638, 
1477, 1362, 1155, 977, 902 cm–1; MS (ESI, +ve) m/z 191 [(M+Na)+, 100%]; HRMS 
[(M+H)+ calcd for C9H13O3 169.0859, found 169.0856. 
Concentration of fraction B (Rf = 0.5 in 2:2.5:5.5 v/v/v ethyl acetate/ 
dichloromethane/hexane) gave compound 17 (25 mg, 18%) as a clear, colorless oil, 
[α]D = −206 (c = 0.2, CHCl3): 1H NMR (400 MHz, CDCl3) δ 5.99 (m, 1H), 5.57 (m, 
1H), 5.38 (broad s, 1H), 4.59 (t, J = 4.3 Hz, 1H), 3.92 (d, J = 6.3 Hz, 1H), 3.71 (m, 
1H), 2.75-2.42 (complex m, 3H), 2.15 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 206.4 
(C), 128.5 (CH), 127.9 (CH), 103.0 (CH), 72.7 (CH2), 71.2 (CH), 45.3 (CH2), 38.7 
(CH), 30.4 (CH3); IR νmax 2956, 2887, 1714, 1638, 1408, 1359, 1247, 1120, 1019, 
919, 870, 713 cm–1; MS (ESI, +ve) m/z 191 [(M+Na)+, 100%], 169 [(M+H)+, <1]; 
HRMS [(M+H)+ calcd for C9H13O3 169.0859, found 169.0855.  
Compound 18. Sodium hydride (76 mg, 60% dispersion in mineral oil, 1.9 mmol) 
was added, with caution, to a magnetically stirred solution of compound 4 (122 mg, 
0.95 mmol) and 2,2,6-trimethyl-1,3-dioxin-4-one (14)16 (180 µL, 1.37 mmol) in THF 
(10 mL) maintained under a nitrogen atmosphere at 0 °C. After stirring for 1 h the 
reaction mixture was quenched with a small amount of ice then concentrated under 
reduced pressure. The residue thus obtained was subjected to flash chromatography 
(silica, 1:2 ethyl acetate/petroleum ether elution) to afford, after concentration of the 
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relevant fractions (Rf = 0.3 in 4:2.5:5.5 v/v/v ethyl acetate/dichloromethane/hexane), 
compound 18 and ca. 15% of a mono-enolic tautomer (181 mg, 90%) as a clear, 
colorless oil, [α]D = −261 (c = 0.2, CHCl3): 1H NMR (400 MHz, CDCl3) δ (major 
tautomer) 6.33 (dd, J = 9.8 and 4.7 Hz, 1H), 5.78 (m, 1H), 5.55 (s, 1H), 4.82 (m, 1H), 
4.75 (t, J = 4.4 Hz, 1H), 3.71 (m, 2H), 3.50 (s, 2H), 2.26 (s, 3H); 13C NMR (100 
MHz, CDCl3) δ (major tautomer) 200.2 (C), 166.3 (C), 133.1 (CH), 122.3 (CH), 
100.1 (CH), 70.5 (CH), 69.2 (CH2), 67.1 (CH), 50.0 (CH2), 30.3 (CH3); IR νmax 2969, 
2896, 1743, 1717, 1647, 1411, 1362, 1259, 1150, 1126, 1020, 871 cm–1; MS (ESI, 
+ve) m/z 235 [(M+Na)+, 100%]; HRMS [(M+Na)+ calcd for C10H12O5Na 235.0582, 
found 235.0583. 
Compounds 16 and 17 (from compound 18). Following the same procedure as 
described above, compound 18 (34 mg, 0.16 mmol) was converted into a mixture of 
compounds 16 (11 mg, 41%) and 17 (4 mg, 15%). Each of these products was 
identical with an authentic sample. 
Compound 19. A magnetically stirred solution of compound 16 (69 mg, 0.410 mmol) 
in THF (10 mL) maintained under a nitrogen atmosphere at 0 °C was treated 
methylmagnesium bromide (280 µL of a 3.0 M solution in THF, 0.84 mmol). After 
0.5 h the reaction mixture was quenched with a small amount of ice then concentrated 
under reduced pressure. The residue thus obtained was subjected to flash 
chromatography (silica, 2:1 v/v ethyl acetate/hexane elution). Concentration of the 
appropriate fractions (Rf = 0.3 in 8:2.5:5.5 v/v/v ethyl acetate/dichloro-
methane/hexane) gave compound 19 (71 mg, 93%) as a clear, colorless oil, [α]D = 
+203 (c = 0.1, CHCl3): 1H NMR (400 MHz, CDCl3) δ 5.83 (m, 1H), 5.73 (m, 1H), 
5.45 (d, J = 3.2 Hz, 1H), 4.68 (m, 1H), 3.97 (m, 1H), 3.64 (dd, J = 7.4 and 2.2 Hz, 
1H), 2.13 (m, 1H), 1.94 (dd, J = 14.7 and 6.8 Hz, 1H), 1.62 (dd, J = 14.7 and 5.1 Hz, 
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1H), 1.41 (s, 1H), 1.28 (s, 3H), 1.26 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 130.7 
(CH), 126.6 (CH), 96.0 (CH), 76.3 (CH), 71.2 (C), 67.6 (CH2), 45.2 (CH2), 39.7 
(CH), 30.7 (CH3), 29.9 (CH3); IR νmax 3447, 2959, 2895, 1638, 1472, 1380, 1171, 
1141, 1107, 965, 903 cm–1; MS (EI, 70 eV) m/z 184 (M+•, 5%), 169 (79), 109 (40), 95 
(51), 81 (100), 59 (73), 43 (60); HRMS M+• calcd for C10H16O3 184.1099, found 
184.1104. 
Compound 20. A magnetically stirred solution of compound 19 (70 mg, 0.38 mmol) 
in dichloromethane (20 mL) maintained under a nitrogen atmosphere at 0 °C was 
treated with pyridine (615 µL, 7.60 mmol), 3,5-dinitrobenzoyl chloride (175 mg, 0.76 
mmol) and DMAP (95 mg, 0.78 mmol). The ensuing mixture warmed to 22 °C and 
stirred at this temperature for 18 h then concentrated under reduced pressure. The 
residue thus obtained was subjected to flash chromatography (silica, 1:5 v/v ethyl 
acetate/petroleum ether elution) and concentration of the appropriate fractions (Rf = 
0.4 in 2:2.5:5.5 v/v/v ethyl acetate/dichloromethane/hexane) gave compound 20 (128 
mg, 89%) as a white, crystalline solid, m.p. = 131-133 °C,  [α]D = +94 (c = 0.1, 
CHCl3): 1H NMR (400 MHz, CDCl3) δ 9.21 (t, J = 2.2 Hz, 1H), 9.10 (d, J = 2.2 Hz, 
2H), 5.88 (m, 1H), 5.75 (m, 1H), 5.51 (d, J = 3.2 Hz, 1H), 4.52 (m, 1H), 4.00 (m, 1H), 
3.65 (dd, J = 7.5 and 2.2 Hz, 1H), 2.30 (d, J = 6.6 Hz, 2H), 2.14 (m, 1H), 1.72 (s, 3H), 
1.71 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 161.4 (C), 148.8 (C), 135.5 (C), 129.4 
(CH), 129.0 (CH), 127.3 (CH), 122.3 (CH), 96.2 (CH), 86.0 (C), 76.3 (CH), 67.3 
(CH2), 43.7 (CH2), 39.1 (CH), 26.6 (CH3), 26.2 (CH3); IR νmax 3101, 2980, 2895, 
1725, 1628, 1544, 1344, 1292, 1266, 1172, 1126, 904, 730, 722 cm–1; MS (ESI, +ve) 
m/z 401 [(M+Na)+, 100%]; HRMS [(M+Na)+ calcd for C17H18N2O8Na 401.0955, 
found 401.0952. 
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Compound 21. A magnetically stirred solution of compound 17 (30 mg, 0.178 mmol) 
in THF (5 mL) maintained under a nitrogen atmosphere at 0 °C was treated with 
methylmagnesium bromide (120 µL of a 3.0 M solution in THF, 0.36 mmol). After 
stirring for 0.5 h the reaction mixture was quenched with a small amount of ice then 
concentrated under reduced pressure. The residue thus obtained was subjected to flash 
chromatography (silica, 2:1 v/v ethyl acetate/hexane elution) and concentration of the 
appropriate fractions (Rf = 0.3 in 8:2.5:5.5 v/v/v ethyl acetate/dichloro-
methane/hexane) gave compound 21 (28 mg, 85%) as a clear, colorless oil,  [α]D = 
−192 (c = 0.1, CHCl3): 1H NMR (400 MHz, CDCl3) δ 5.96 (m, 1H), 5.68 (m, 1H), 
5.60 (s, 1H), 4.58 (t, J = 4.3 Hz, 1H), 3.90 (d, J = 6.2 Hz, 1H), 3.71 (m, 1H), 2.24 (m, 
1H), 1.73 (dd, J = 14.7 and 6.2 Hz, 1H), 1.49 (dd, J = 14.7 and 5.5 Hz, 1H), 1.41 (s, 
1H), 1.26 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 130.1 (CH), 127.0 (CH), 104.4 
(CH), 72.8 (CH2), 71.1 (C), 71.0 (CH), 44.9 (CH2), 40.3 (CH), 30.2 (CH3), 30.0 
(CH3); IR νmax 3448, 2969, 2885, 1638, 1471, 1364, 1115, 1018, 905, 874 cm–1; MS 
(ESI, +ve) m/z 207 [(M+Na)+, 100%]; HRMS [(M+Na)+ calcd for C10H16O3Na 
207.0997, found 207.0996. 
Compound 22. A magnetically stirred solution of compound 21 (30 mg, 0.16 mmol) 
in dichloromethane (10 mL) maintained under a nitrogen atmosphere at 0 °C was 
treated with pyridine (265 µL, 3.28 mmol), 3,5-dinitrobenzoyl chloride (75 mg, 0.33 
mmol) and DMAP (40 mg, 0.33 mmol). The resulting mixture was allowed to warm 
to 22 °C and stirred at this temperature for 18 h then concentrated under reduced 
pressure. The residue thus obtained was subjected to flash chromatography (silica, 1:5 
v/v ethyl acetate/petroleum ether elution) and concentration of the appropriate 
fractions (Rf = 0.5 in 2:2.5:5.5 v/v/v ethyl acetate/dichloromethane/hexane) afforded 
compound 22 (56 mg, 90%) as a white, crystalline solid, m.p. = 162-165 °C, [α]D = 
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−97 (c = 0.1, CHCl3): 1H NMR (400 MHz, CDCl3) δ 9.20 (t, J = 2.1 Hz, 1H), 9.10 (d, 
J = 2.1 Hz, 2H), 6.02 (m, 1H), 5.67 (m, 1H), 5.51 (d, J = 1.9 Hz, 1H), 4.65 (t, J = 4.3 
Hz, 1H), 3.91 (d, J = 6.4 Hz, 1H), 3.73 (m, 1H), 2.26 (m, 1H), 2.20-2.05 (complex m, 
2H), 1.70 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 161.4 (C), 148.8 (C), 135.5 (C), 
129.5 (CH), 128.7 (CH), 127.9 (CH), 122.3 (CH), 104.0 (CH), 86.1 (C), 72.8 (CH2), 
71.2 (CH), 43.0 (CH2), 39.7 (CH), 26.6 (CH3), 26.1 (CH3); IR νmax 3099, 2935, 2895, 
1722, 1631, 1544, 1346, 1130, 1116, 1023, 921, 873, 723 cm–1; MS (ESI, +ve) m/z 
401 [(M+Na)+, 100%]; HRMS [(M+Na)+ calcd for C17H18N2O8Na 401.0961, found 
401.0952. 
Compound 23. A magnetically stirred mixture of levoglucosenone (1) (3.78 g, 30.0 
mmol) and water (300 mL) maintained at 22 °C was treated with triethylamine (3.0 
ml, 2.37 mmol). After 1 h the reaction mixture was concentrated under reduced 
pressure and the ensuing residue subjected to flash chromatography (silica, 1:1 v/v 
ethyl acetate/ petroleum ether elution). Concentration of the relevant fractions (Rf = 
0.2) gave compound 2317 (3.11g, 72%) as a clear, yellow oil, [α]D = –203.9 (c = 0.1, 
CH3OH) {lit.17 [α]D = –143 (water) and –255 (CHCl3)}: 1H NMR (400 MHz, CDCl3) 
δ 5.07 (d, J = 1.2 Hz, 1H), 4.61 (dd, J = 5.0 and 2.2 Hz, 1H), 4.16 (d, J = 5.7 Hz, 1H), 
4.04-3.74 (complex m, 2H), 3.37 (broad s, 1H), 2.83 (dd, J = 12.0 and 4.0 Hz, 1H),  
2.46 (d, J = 12.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 199.3, 101.3, 77.4, 70.3, 
65.2, 40.8; IR νmax 3446, 2971, 2912, 1734, 1114, 1008, 961, 907, 867 cm−1; MS (ESI, 
+ve) m/z 199 [(M+Na+MeOH)+, 100%] 167 [(M+Na)+, 10]; HRMS [(M+Na)+ calcd 
for C6H8O4Na 167.0315, found 167.0314. 
TBS Ether of Compound 23. A magnetically stirred solution of compound 23 (432 
mg, 3.00 mmol) and imidazole (408 mg, 6.00 mmol, 2 mole equiv.) in THF (30 mL) 
maintained under nitrogen at 22 °C was treated with TBS-Cl (904 mg, 6.00 mmol, 2 
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mole equiv.). The ensuing solution was heated under reflux for 24 h then cooled to 22 
°C before being diluted with ethyl acetate (100 mL) then washed with NaHCO3 (1 x 
50 mL of a saturated aqueous solution), water (1 x 50 mL) and brine (1 x 50 mL). The 
separated organic layer was then dried (Na2SO4), filtered and concentrated under 
reduced pressure. The residue thus obtained was subjected to flash chromatography 
(silica, 1:20 v/v ethyl acetate/ petroleum ether elution) and concentration of the 
relevant fractions (Rf = 0.2) gave the title ether (563 mg, 73%) as a white, crystalline 
solid, m.p. = 55-58 °C, [α]D = –163.6 (c = 0.1, CHCl3): 1H NMR (400 MHz, CDCl3) δ 
5.13 (s, 1H), 4.53 (m, 1H), 4.22 (m, 1H), 4.05-3.74 (complex m, 2H), 2.79 (dd, J = 
16.7 and 5.6 Hz, 1H), 2.35 (dm, J = 16.7 Hz, 1H), 0.90 (s, 9H), 0.10 (s, 3H), 0.09 (s, 
3H); 13C NMR (100 MHz, CDCl3) δ 198.8, 101.3, 77.9, 71.0, 65.0, 41.1, 25.7, 18.1, –
4.7, –4.8; IR νmax 2956, 2931, 2901, 2858, 1740, 1257, 1119, 1086, 884, 839, 779 
cm−1; MS (ESI, +ve) m/z 313 [(M+Na+MeOH)+, 100%] 281 [(M+Na)+, 2]; HRMS 
[(M+Na)+ calcd for C12H22O4SiNa 281.1180, found 281.1174. 
Compound 24. A magnetically stirred solution of the above-mentioned TBS ether 
(720 mg, 2.78 mmol) in methanol (27 mL) maintained at 0 °C under a nitrogen 
atmosphere was treated, in portions, with NaBH4 (105 mg, 2.78 mmol, 1 mole 
equiv.). The ensuing mixture was stirred at 0 °C for 0.5 h then warmed to 22 °C 
before being concentrated under reduced pressure. The residue thus obtained was 
subjected to flash chromatography (silica, 1:5 v/v ethyl acetate/ petroleum ether 
elution) and so affording two fractions, A and B.  
Concentration of fraction A (Rf = 0.4) gave the α-epimeric form of compound 24 (365 
mg, 49%) as a white, crystalline solid, m.p. = 57-60°C, [α]D = –64.4 (c = 0.1, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 5.37 (t, J = 1.9 Hz, 1H), 4.36 (m, 1H), 4.00-3.67 
(complex m, 3H), 3.52 (m, 1H), 3.09 (d, J = 12.0 Hz, 1H), 2.02 (m, 1H), 1.74 (m, 
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1H), 0.93 (s, 9H), 0.11 (s, 3H), 0.10 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 102.4, 
77.3, 68.2, 67.5, 65.4, 31.1, 25.7, 18.0, –4.8(9), –4.9(4); IR νmax 3547, 2955, 2931, 
2895, 2858, 1257, 1136, 1091, 1017, 921, 877, 838, 778 cm−1; MS (ESI, +ve) m/z 283 
[(M+Na)+, 100%]; HRMS [(M+Na)+ calcd for C12H24O4SiNa 283.1336, found 
283.1330. 
Concentration of fraction B (Rf = 0.2) gave the β-epimeric form of compound 24  
(272 mg, 36%) as a white, crystalline solid, m.p. = 77-79 °C, [α]D = –99.1 (c = 0.1, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 5.34 (s, 1H), 4.30 (m, 1H), 3.87 (m, 1H), 
3.80-3.70 (complex m, 2H), 3.69 (dd, J = 7.7 and 1.0 Hz, 1H), 2.01 (m, 1H), 1.75-
1.50 (complex m, 2H), 0.91 (s, 9H), 0.09 (s, 3H), 0.08 (s, 3H); 13C NMR (100 MHz, 
CDCl3) δ 102.7, 77.2, 68.7, 66.9, 66.3, 35.0, 25.8, 18.1, –4.7(5), –4.8(2); IR νmax 
3446, 3283, 2960, 2957, 2927, 2891, 2857, 1463, 1252, 1096, 1075, 899, 836, 775 
cm−1; MS (ESI, +ve) m/z 283 [(M+Na)+, 100%]; HRMS [(M+Na)+ calcd for 
C12H24O4SiNa 283.1336, found 283.1332. 
Compound 25. A magnetically stirred solution of a ca. 1:1 mixture of the epimeric 
forms of compound 24 (357 mg, 1.37 mmol) and DMAP (170 mg, 1.37 mmol, 1 mole 
equiv.) in THF (7 mL) maintained at 22 °C under a nitrogen atmosphere was treated 
with acetic anhydride (280 mg, 2.75 mmol, 2 mole equiv.). The ensuing mixture was 
stirred for 18 h then concentrated under reduced pressure. The residue thus obtained 
was subjected to flash chromatography (silica, 1:20 v/v ethyl acetate/ petroleum ether 
elution) to afford two fractions, A and B. 
Concentration of fraction A [Rf = 0.2(5)] gave the α-epimeric form of compound 25 
(414 mg, 99% based on the relevant epimeric form of the precursor) as clear, 
colorless oil, [α]D = –58.2 (c = 0.2, CHCl3): 1H NMR (400 MHz, CDCl3) δ 5.43 (t, J 
= 1.7 Hz, 1H), 4.59 (m, 1H), 4.42 (m, 1H), 3.87-3.70 (complex m, 2H), 3.66 (m, 1H), 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 31
2.11 (m, 1H), 2.09 (s, 3H), 1.76 (dm, J = 15.9 Hz, 1H), 0.92 (s, 9H), 0.09 (s, 3H), 
0.07 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 170.7, 99.6, 67.4, 66.3, 65.5, 29.0, 25.8, 
21.2, 18.1, –4.7, –4.8 (one signal obscured or overlapping); IR νmax 2955, 2930, 2895, 
2857, 1728, 1372, 1245, 1143, 1106, 1021, 1001, 893, 835, 774 cm−1; MS (ESI, +ve) 
m/z 325 [(M+Na)+, 100%], 303 [(M+H)+, 8]; HRMS [(M+H)+ calcd for C14H27O5Si 
303.1622, found 303.1632. 
Concentration of fraction B (Rf = 0.2) gave the β-epimeric form of compound 25  
(414 mg, 99% based on the relevant epimeric form of the precursor) as a clear, 
colorless oil, [α]D = –103.9 (c = 0.1, CHCl3); 1H NMR (400 MHz, DCl3) δ 5.39 (t, J 
= 1.5 Hz, 1H), 4.95 (m, 1H), 4.33 (m, 1H), 3.85-3.65 (complex m, 3H), 2.03 (s, 3H), 
1.95 (m, 1H), 1.79 (m, 1H), 0.88 (s, 9H), 0.06 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 
170.2, 100.2, 77.5, 69.5, 68.6, 66.4, 30.8, 25.7, 21.0, 18.1, –4.7(9), –4.8(6); IR νmax 
2955, 2930, 2895, 2857, 1734, 1366, 1238, 1146, 1123, 1100, 1045, 1031, 840, 775 
cm−1; MS (ESI, +ve) m/z 325 [(M+Na)+, 100%], 303 [(M+H)+, 3]; HRMS [(M+H)+ 
calcd for C14H27O5Si 303.1622, found 303.1632. 
Compound 26. A magnetically stirred solution of compound 25 (421 mg, 1.39 mmol) 
in THF (7 mL) maintained at 22 °C was treated with TBAF in THF (1.67 ml of an 1 
M solution in THF, 1.67 mmol, 1.2 mole equiv.) The ensuing mixture was stirred at 
22 °C for 5 h then concentrated under reduced pressure and the residue thus obtained 
subjected to flash chromatography (silica, diethyl ether elution) and so affording two 
fractions, A and B. 
Concentration of fraction A [Rf = 0.2(5)] gave the α-epimeric form of compound 26 
(238 mg, 91%) as a yellow, crystalline solid, m.p. = 56-62 °, [α]D = –51.4 (c = 0.1, 
CHCl3): 1H NMR (400 MHz, CDCl3) δ 5.42 (s, 1H), 4.65 (m, 1H), 4.54 (m, 1H), 
3.80-3.72 (complex m, 2H), 3.59 (m, 1H), 2.78 (broad s, 1H), 2.17 (m, 1H), 2.11 (s, 
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3H), 1.84 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 169.9, 99.4, 77.4, 68.2, 66.2, 65.6, 
28.6, 21.1; IR νmax 3483, 2971, 2901, 1727, 1373, 1243, 1139, 1078, 1002, 973, 921, 
889 cm−1; MS (ESI, +ve) m/z 211 [(M+Na)+, 100%], 189 [(M+H)+, <1]; HRMS 
[(M+H)+ calcd for C8H13O5 189.0757, found 189.0754. 
Concentration of fraction A (Rf = 0.2) gave the β-epimeric form of compound 26 (236 
mg, 90%) as a clear, colorless oil, [α]D = –144.9 (c = 0.14, CH3OH): 1H NMR (400 
MHz, CDCl3) δ 5.44 (s, 1H), 4.96 (m, 1H), 4.50 (m, 1H), 3.95-3.80 (complex m, 3H), 
2.14 (m, 1H), 2.08 (s, 3H), 1.85 (m, 1H) (signal due to hydroxyl group proton not 
observed); 13C NMR (100 MHz, CDCl3) δ 170.3, 100.3, 68.8, 68.1, 66.6, 30.2, 21.0 
(one resonance obscured or overlapping); IR νmax 3450, 2971, 2901, 1730, 1370, 
1235, 1144, 1042, 980, 896 cm−1; MS (ESI, +ve) m/z 211 [(M+Na)+, 100%], 189 
[(M+H)+, <1]; HRMS [(M+H)+ calcd for C8H13O5 189.0757, found 189.0754. 
Compound 2. A magnetically stirred solution of compound 26 (261 mg, 1.39 mmol) 
in dichloromethane (7 mL) maintained at 22 °C was treated, in one portion, with PCC 
(900 mg, 4.16 mmol, 3 mole equiv.). The ensuing mixture was stirred for 24 h then 
treated with Celite™ (1.0 g) before being filtered through a sintered glass funnel. The 
filtrate was concentrated under reduced pressure and the residue thus obtained was 
subjected to flash chromatography (silica, 1:2 v/v ethyl acetate/petroleum ether 
elution). Concentration of the relevant fractions (Rf = 0.4) gave a light-yellow oil. 
This oil was dissolved in acetonitrile (7.0 ml) and while being maintained at 22 °C 
with magnetic stirring the resulting solution was treated, in one portion, with sodium 
acetate (341 mg, 3 mole equiv.). The ensuing mixture was heated under reflux for 8 h 
then cooled and concentrated under reduced pressure. The dark oil thus obtained was 
subjected to column chromatography (silica, 1:9 v/v ethyl acetate/petroleum ether 
elution) to give, after concentration of the relevant fractions (Rf = 0.2), compound 2 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 33
(278 mg, 53%) as a clear, colorless oil. This material was identical, in all respects, 
with an authentic sample.5  
Compound 27. A magnetically stirred solution of compound 23 (1.56 g, 10.83 mmol) 
in methanol (36 mL) maintained at 0 °C was treated, in one portion, with NaBH4 (410 
mg, 10.83 mmol, 1 mole equiv.).  The ensuing mixture was stirred for 0.5 h at 0 °C 
then warmed to 22 °C before being concentrated under reduced pressure. The residue 
thus obtained was subjected to flash column chromatography (silica, 1:20 v/v 
methanol/ethyl acetate elution) and concentration of the relevant fractions (Rf = 0.2) 
gave compound 2717 (1.12 g, 72%) as a clear, colorless oil, [α]D = –155.0 (c = 0.1, 
CH3OH): 1H NMR (400 MHz, CD3OD) δ 5.22 (s, 1H), 4.38 (m, 1H), 3.88-3.68 
(complex m, 4H), 1.92 (m, 1H), 1.71 (m, 1H) (signals due to hydroxyl group protons 
not observed); 13C NMR (100 MHz, CD3OD) δ 102.9, 76.7, 67.5, 66.1, 66.0, 33.0; IR 
νmax 3368, 2957, 2900, 1138, 1049, 968, 900, 864 cm−1; MS (ESI, +ve) m/z 169 
[(M+Na)+, 100%]; HRMS [(M+Na)+ calcd for C6H10O4Na 169.0471, found 169.0476. 
Compound 28. A magnetically stirred solution of compound 27 (146 mg, 1.0 mmol) 
in acetone (10 mL) maintained at 22 °C was treated with PDC (1.13 g, 3.0 mmol, 3 
mole equiv.) and the ensuing mixture heated at 40 °C for 12 h before being cooled the 
treated with Celite (1.0 g). The ensuing mixture was filtered through a sintered glass 
funnel and the filtrate concentrated under reduced pressure. The residue thus obtained 
was subjected to flash column chromatography (silica, 1:4 v/v diethyl ether/petroleum 
ether elution) afforded two fractions, A and B. 
Concentration of fraction A (Rf = 0.2) gave compound 2317 (14 mg, 10%) as a clear, 
yellow oil that was identical in all respects with an authentic sample. 
Concentration of fraction B (Rf = 0.1) gave compound 2819 (56 mg, 39%) as a clear, 
colorless oil, [α]D = –96.1 (c = 0.1, CH3OH): 1H NMR (400 MHz, CDCl3) δ 5.58 (s, 
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1H), 4.50 (m, 1H), 4.15 (m, 1H), 4.04-3.85 (complex m, 2H), 2.94 (dd, J = 17.2 and 
7.7 Hz, 1H), 2.31 (dd, J = 17.2 and 7.0 Hz, 1H), 2.10 (broad s, 1H); 13C NMR (100 
MHz, CDCl3) δ 202.5, 101.3, 78.0, 69.6, 66.9, 43.0; IR νmax 3441, 2980, 2901, 1733, 
1720, 1133, 1120, 1066, 1020, 966, 834, 875 cm−1; MS (ESI, +ve) m/z 199 
[(M+Na+MeOH)+, 100%] 167 [(M+Na)+, 5]; HRMS [(M+Na)+ calcd for C6H8O4Na 
167.0322, found 167.0320. 
Compound 2. A magnetically stirred solution of compound 28 (290 mg, 2.0 mmol) 
and trimethylamine (577 µL, 4.0 mmol, 2 mole equiv.) in dichloromethane (20 mL) 
maintained at 0 °C was treated with p-TsCl (572 mg, 3.0 mmol, 1.5 mole equiv.) 
After 0.5 h the reaction mixture was warmed to 22 °C, stirred at this temperature for 
24 h then concentrated under reduced pressure. The residue thus obtained was 
subjected to flash chromatography (silica, 1:9v/v ethyl acetate/ petroleum ether 
elution) and concentration of the relevant fractions (Rf = 0.2) gave compound 2 (163 
mg, 65%) as a clear, colorless oil. 
Compound 30. Step i: A magnetically stirred solution of compound 2 (188 mg, 1.49 
mmol) in methanol (8 mL) maintained at 0 °C was treated with CeCl3•7H2O (555 mg, 
1.49 mmol) then, in portions, with NaBH4 (56 mg, 1.48 mmol). The ensuing mixture 
was stirred at 0 °C for 1 h before being filtered through a short pad of TLC grade 
silica gel that was washed with ethyl acetate (100 mL). The combined filtrates were 
concentrated under reduced pressure to give a white solid presumed to contain allylic 
alcohol 29.5,22 
Step ii: The crude product from step i was dissolved in pyridine (10 mL) and the 
resulting solution, while being stirred magnetically at 22 °C, was treated with acetic 
anhydride (700 µL, 7.40 mmol) then DMAP (12 mg). The resulting solution was 
stirred for 4 h then concentrated under reduced pressure. The ensuing residue was 
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subjected to flash chromatography (silica, 4:1 v/v hexane/ethyl acetate elution) and 
concentration of the appropriate fractions (Rf = 0.4) gave compound 30 (224 mg, 
88%) as a clear, colorless oil, [α]D = –52.5 (c = 0.2, CHCl3). The 1H and 13C NMR 
spectral data obtained on this compound matched those reported22 previously.  
Compounds 10 and 11 (from compound 30). Following the same procedure as 
described above for effecting the Tsuji-Trost reactions of allylic acetates 5 and 6, 
compound 30 was converted into a chromatographically separable mixture of 
compounds 10 (42%) and 11 (53%). Each of these products was identical with an 
authentic sample. 
 
X-ray Crystallographic Studies 
Crystallographic Data.  
Compound 8. C8H8Cl3NO3, M = 272.51, T = 150 K, orthorhombic, space group 
P212121, Z = 4, a = 6.0047(1) Å, b = 9.2700(2) Å, c = 18.8140(4) Å; V = 1047.25(4) 
Å3, Dx = 1.728 g cm–3, 2077 unique data (2θmax = 145.4°), R = 0.023 [for 2043 
reflections with I > 2.0σ(I)]; Rw = 0.060 (all data), S = 1.01. 
Compound 9. C8H8Cl3NO3, M = 272.51, T = 150 K, monoclinic, space group P21, Z = 
2, a = 6.2433(2) Å, b = 9.1470(2) Å, c = 9.6606(2) Å; β = 90.256(2)°; V = 551.69(2) 
Å3, Dx = 1.640 g cm–3, 2026 unique data (2θmax = 144.8°), R = 0.019 [for 2012 
reflections with I > 2.0σ(I)]; Rw = 0.047 (all data), S = 1.00. 
Compound 10. C11H14O6, M = 242.23, T = 150 K, monoclinic, space group P21, Z = 2, 
a = 8.1650(2) Å, b = 8.49383(13) Å, c = 8.7258(2) Å; β = 107.831(2)°; V = 576.08(2) 
Å3, Dx = 1.396 g cm–3, 1828 unique data (2θmax = 144.4°), R = 0.024 [for 1795 
reflections with I > 2.0σ(I)]; Rw = 0.057 (all data), S = 1.00. 
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Compound 11. C11H14O6, M = 242.23, T = 150 K, monoclinic, space group P21, Z = 2, 
a = 5.80882(5) Å, b = 7.49449(6) Å, c = 13.20425(12) Å; β = 91.2938(8)°; V = 
574.69(1) Å3, Dx = 1.400 g cm–3, 2124 unique data (2θmax = 144.4°), R = 0.022 [for 
2111 reflections with I > 2.0σ(I)]; Rw = 0.057 (all data), S = 1.00. 
Compound 20. C17H18N2O8, M = 378.34, T = 150 K, monoclinic, space group P21, Z 
= 2, a = 9.7352(6) Å, b = 5.8003(4) Å, c = 15.9527(15) Å; β = 106.367(8)°; V = 
864.30(8) Å3, Dx = 1.454 g cm–3, 2884 unique data (2θmax = 147.4°), R = 0.058 [for 
2522 reflections with I > 2.0σ(I)]; Rw = 0.171 (all data), S = 1.01. 
Compound 22. C17H18N2O8, M = 378.34, T = 150 K, orthorhombic, space group 
P212121, Z = 4, a = 5.6020(1) Å, b = 10.3437(1) Å, c = 29.2615(4) Å; V = 1695.57(2) 
Å3, Dx = 1.482 g cm–3, 3312 unique data (2θmax = 147.2°), R = 0.029 [for 3312 
reflections with I > 2.0σ(I)]; Rw = 0.076 (all data), S = 1.00. 
Compound 24 (α-epimer). C12H24O4Si, M = 260.40, T = 150 K, orthorhombic, space 
group P212121, Z = 4, a = 6.45626(7) Å, b = 11.44113(15) Å, c = 19.3950(2) Å; V = 
1432.65(3) Å3, Dx = 1.208 g cm–3, 2893 unique data (2θmax = 147.8°), R = 0.029 [for 
2858 reflections with I > 2.0σ(I)]; Rw = 0.079 (all data), S = 1.00. 
Structure Determination. Images for compounds 8, 9, 10, 11, 20, 22 and 24 (α-
epimer) were measured on a diffractometer (Cu Kα, mirror monochromator, λ = 
1.54184 Å) fitted with an area detector and the data extracted using the CrysAlis 
package.23 The structure solutions for all seven compounds were solved by direct 
methods (SIR92)24 then refined using the CRYSTALS program package.25 Atomic 
coordinates, bond lengths and angles, and displacement parameters have been 
deposited at the Cambridge Crystallographic Data Centre (CCDC nos., 1587832, 
1587833, 1587834, 1587835, 1587836, 1587837 and 1587838). These data can be 
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obtained free-of-charge via www.ccdc.cam.ac.uk/data_request/cif, by emailing 
data_request@ccdc.cam.ac.uk, or by contacting The Cambridge Crystallographic 
Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033. 
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